Pherecydes Pharma Email Format

Biotechnology ResearchPays de la Loire, France2-10 Employees

Pherecydes Pharma is a small biotechnology company focused on developing antibacterial therapies that use bacteriophages to treat human infections, particularly those resistant to standard antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on human cells. The company pursues precision phagotherapy, tailoring treatments to the activity of the phages against the bacterial strain responsible for an infection.

Based in Nantes, Pays de la Loire, France, Pherecydes has identified Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli as priority targets, bacteria noted by the WHO among the most dangerous for hospital infections. Some of its phages have been used in compassionate treatments in France under ANSM supervision, and in 2023 the company announced partnerships with Pharmafocuseurope and with Erytech aimed at expanding its global phage-therapy footprint.

Get verified Pherecydes Pharma emails free

Company overview Employee directory